Ethicon, Inc. v. United States Surgical Corp.
This text of 954 F. Supp. 51 (Ethicon, Inc. v. United States Surgical Corp.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
RULING AND ORDER ON DEFENDANTS’ MOTION TO DISMISS
Defendant United States Surgical Corporation (USSC) and intervenor-defendant Young Jae Choi have moved to dismiss the complaint of plaintiffs Ethicon, Inc. and Inbae Yoon, M.D., which charges USSC with infringing U.S. Patent No. 4,535,773 (the ’773 Patent). The motion is based on the court’s order granting USSC’s motion to correct the ’773 patent to add Choi as a coinventor, Choi having previously granted USSC an exclusive license, retroactive to the date the ’773 patent was issued to Yoon, to make and sell the inventions covered by the patent. Ethicon, Inc. v. U.S. Surgical Corp., 937 F.Supp. 1015 (D.Conn.1996).
Plaintiffs oppose dismissal of their complaint on the grounds that (1) Choi’s licensing agreement with USSC does not encompass the claims of the patent USSC is charged with infringing; (2) dismissal of the complaint would be inequitable because Choi is not a coinventor of those claims; and (3) a co-owner’s grant of a retroactive license does not protect the licensee against liability to another co-owner for past infringement.
After careful consideration of the parties’ briefs and oral arguments, I conclude that dismissal is appropriate.
The terms of the agreement between Choi and USSC reflect a mutual intention to create the broadest possible license. Plaintiffs’ contention that the agreement should be interpreted to encompass fewer than all the claims of the ’773 patent contradicts their own previous position in this litigation, advanced numerous times in writing, that the agreement encompasses all of Choi’s rights under the patent. Moreover, plaintiffs’ revisionist interpretation is contrary to Choi’s unequivocal testimony, both in his affidavit and at the hearing on the motion to dismiss, that he intended to license all his rights under the ’773 patent to USSC. Given Choi’s testimony, no reasonable person could conclude that his agreement with USSC covers less than all his rights.
Dismissal of the complaint based on Choi’s licensing agreement with USSC does not result in injustice to either plaintiff. Yoon argues that giving effect to Choi’s agreement with USSC would be unjust because, had Bushnell known about Choi’s inventive contributions before he filed the application for the ’773 patent, he would have deleted the claims as to which Choi was arguably a coinventor. See Pis.’ Mem. In Opp’n to Defs.’ *53 Mot. for J. (“Pis.’ Mem.”) at 17-18. However, the reason Bushnell didn’t know about Choi’s inventive contributions is that Yoon didn’t tell him. Yoon claimed the benefit of Choi’s inventive contributions while causing Bushnell to believe that any contribution Choi might have made was limited to that of a draftsman. See Ethicon, 937 F.Supp. at 1023.
Yoon’s failure to disclose Choi as a coinventor was a breach of his informal partnership agreement with Choi, which governed their collaboration on the safety trocar project. See Ethicon, 937 F.Supp. at 1022. Pursuant to that agreement, Yoon had a duty to inform Choi of his intention to file a patent application and to share any profits on any patentable product. Yoon’s breach deprived Choi of an opportunity to assert and protect his interest in the matter before the application was filed and the patent was issued. Id. at 1038. Equity will not aid a wrongdoer whose predicament is of his own making, as Yoon’s is here.
Ethicon argues that giving effect to Choi’s agreement with USSC would undermine the value of its investment in safety-shielded trocars. See Pis.’ Mem. at 19. However, Ethicon will be able to continue to sell safety-shielded trocars, which have already accounted for more than $300 million in revenues for the company. See Defs.’ Mem. in Further Support of M. for J. at 29.
Turning to the plaintiffs’ remaining argument in opposition to the motion to dismiss, it is well settled that, in the absence of an agreement to the contrary, one co-owner of a patent cannot sue a third party for infringement unless all other co-owners of the patent voluntarily join the suit. See Cilco, Inc. v. Copeland Intralenses, Inc., 614 F.Supp. 431, 434 (S.D.N.Y.1985) (co-owner cannot be made involuntary plaintiff in infringement suit unless it has previously agreed to - give other co-owner unilateral right to sue). In the absence of such an agreement between Yoon and Choi, Choi can protect USSC against plaintiffs’ infringement suit simply by declining to consent to further prosecution of the suit. Plaintiffs cite no authority that would permit them to proceed with their suit against USSC without Choi’s consent. 1
Plaintiffs argue that allowing Choi to deprive them of a right to sue USSC for accrued damages for past infringement would be contrary to the Federal Circuit’s recent decision in Schering Corp. v. Zeneca Inc., 104 F.3d 341 (Fed.Cir.1997). 2 However, that case is clearly distinguishable. The issue in Schering was whether a unilateral right to sue granted by a co-ownership agreement limited the right of either co-owner to license third parties. The court did not address the issue whether, in the absence of such an agreement, one co-owner may sue a third party for infringement without the consent of another co-owner. Indeed, the court noted that, as a general proposition, “unless the co-owner has given up these rights through an ‘agreement to the contrary,’ 35 U.S.C. § 262, the co-owner may not be prohibited from exploiting its rights in the patent, including the right to grant licenses to third parties on whatever conditions the co-owner chooses.” Id. at 344. 3
*54 Permitting Choi to deprive Ethicon and Yoon of their claim against USSC for patent infringement is arguably inconsistent with the public interest in promoting investment in patented inventions. Cf. Merchant v. Levy, 92 F.3d 51, 57 (2d Cir.1996) (Newman, J.) (dismissing complaint for declaration of copyright co-ownership based on statute of limitations “promotes principles of repose integral to a properly functioning copyright market”). However, 35 U.S.C. § 256 does not limit the time during which the inventor-ship of an issued patent can be corrected by a court. See Advanced Cardiovascular Systems, Inc. v. SciMed Life Systems, Inc., 988 F.2d 1157, 1162 (Fed.Cir.1993). “Section 256 thus serves the public policy of preserving property rights from avoidable forfeiture. See Henderson v. Carbondale Coal & Coke Co., 140 U.S. 25, 33, 11 S.Ct.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
954 F. Supp. 51, 1997 U.S. Dist. LEXIS 1483, 1997 WL 64082, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ethicon-inc-v-united-states-surgical-corp-ctd-1997.